Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GLPGF:US

48.8000 USD 1.1000 2.20%

As of 20:10:01 ET on 05/20/2015.

Snapshot for Galapagos NV (GLPGF)

Open: 49.1400 Day's Range: 48.8000 - 49.1400 Volume: 1,500
Previous Close: 49.9000 52wk Range: 14.3500 - 52.1500 1-Yr Rtn: -

Stock Chart for GLPGF

No chart data available.
  • GLPGF:US 48.8000
  • 1D
  • 1M
  • 1Y
49.9000
Interactive GLPGF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GLPGF

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 23.5797
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2015) 1.8840
Est. PEG Ratio 1.0252
Market Cap (M USD) 1,874.07
Shares Outstanding (M) 38.40
30 Day Average Volume 121
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GLPGF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GLPGF

Galapagos NV operates as a clinical stage biotech company. The Company develops and commercializes novel medicines and progressing pipelines in biotech with phase 2 programs, phase 1 programs, pre-clinical, and discovery programs.

Onno Van De StolpeCEO/FounderBart FiliusChief Financial Officer
Piet WigerinckChief Scientific OfficerAndre HoekemaSenior VP:Corporate Dev
More Company Profile & Key Executives for GLPGF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil